Kosan Biosciences Incorporated, a cancer therapeutics company, focuses on developing various classes of anticancer agents through clinical development. Its product KOS-953, a Hsp90 inhibitor is in Phase III clinical trial in combination with Velcade for multiple myeloma, as well as in Phase II clinical trial in combination with Herceptin for HER2-positive metastatic breast cancer. The company's product portfolio also includes KOS-1584, an epothilone anticancer product candidate evaluated in dose-escalating Phase I clinical trial in patients with solid tumors; KOS-1803, a preclinical stage product for cancer; KOS-2187, a potent motilin receptor agonist that is in Phase I clinical testing for the treatment of GERD. In addition, Kosan Biosciences develops KOS-2464, a preclinical stage product for cancer. The company was founded in 1995 and is based in Hayward, California. As of June 25, 2008, Kosan Biosciences Incorporated operates as a subsidiary of Bristol-Myers Squibb Co.

Genomatica develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability, and performance. Genomatica has earned widespread acclaim for its technology; has commercialized processes for the chemical butanediol (for biodegradable plastics and apparel) and for butylene glycol (cosmetics and personal care), and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide(TM) butylene glycol.

GeneChem Inc. is specialized in the development of health-related substances such as functional oligosaccharides, new bio-medicines, and gene therapy products, on the basis of the *omics technologies including nucleic acid chemistry, phosphate chemistry, and transglycosylation technology. Currently, GeneChem Inc. is the only company capable of manufacturing high purity 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) in bulk scale. GeneChem Inc. also manufactures AquaGG® (glyceryl glucoside) of high purity for cosmetic applications.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

GenoTech Corp. engages in the production, sales of biotechnology related products and in provision of technical and academic services. It operates through the following business areas: Bio, Gene Synthesis, and Genetic Analysis. The Bio business area offers bio-technology based products and services for improvement of human health, disease prevention, diagnosis and treatment. The Gene Synthesis business area provides products used for biotechnology research and development such as oligonucleotides, enzymes, cloning technology kits and others. The Genetic Analysis business area offers genome analytic and genome sequencing services. The company was founded on July 8, 1997 and is headquartered in Daejeon, South Korea.

Combinature Biopharm AG discovers and develops drugs. It provides natural compound based clinical development candidates, particularly in the areas of infectious diseases and oncology. It applies its technologies to make improved versions of known natural product pharmaceuticals and to advance such improved drug candidates into pre-clinical and clinical trials. The company was founded in 2000 and is headquartered in Berlin, Germany.

Shanghai Laiyi Biological Drug Research and Development Center Co., Ltd., established on 2001-12-03, The scope of business includes the research of biopharmaceuticals,Technical services in development and related fields,technology development,technical consulting,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guoke Xinyan International Technology Transfer Co., Ltd., established on 2020-09-02, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Intellectual Property Services,Entrepreneurial Space Services,Business incubator management,Corporate Image Planning,Business Management Consulting,Business agency service,Business Registration Agent,account Serive,Exhibition display service,Own house rental,Trusted Housing Lease,Organize cultural and artistic exchange activities,Industrial Design Services,Business Consulting(Does not include investment consulting),Economic Information Consulting,Information Consulting Service(Not including licensing information consulting services),software development,design,web page creation,Engineering Management Services,Cloud Infrastructure Services,Cloud software service,Chemical Products(No licensed chemical products),Computer hardware and software,Electrical Equipment,Sales of instrumentation,Financial Advisory.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Various construction activities,Engineering cost consulting business,Technology Import and Export,Import and export agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.